Committed to providing exceptional care and continued support to patients, families and caregivers.

Menu

Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy

Wednesday, November 2, 2016  |  Filed under "Press Releases"

Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients with Metastatic Renal Cell Carcinoma from an On-going Observational IL-2 Clinical Trial: PROCLAIM

“manuscript in publication”

More articles »